Skip to main content
Premium Trial:

Request an Annual Quote

Diamond Healthcare, AssureRx Team on Personalized Medicine Program for Behavioral Health

NEW YORK (GenomeWeb News) – AssureRx and Diamond Healthcare will collaborate on a personalized medicine platform for use by physicians treating patients with behavioral health conditions, AssureRx said today.
 
Through the alliance, AssureRx will gain access to the managerial and clinical expertise and industry relationships of Diamond Healthcare, which provides behavioral health management and consulting services, to help develop its first commercial product for the behavioral health market.
 
Cincinnati-based AssureRx is developing products based on pharmacogenetics to help guide physicians in making treatment decisions. The platform is based on technology licensed from the Mayo Clinic and the Cincinnati Children’s Hospital.
 
As part of the alliance with Diamond, George White, president of Diamond Healthcare, has joined AssureRx’s board of directors.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.